Neogen (NASDAQ:NEOG) Posts Quarterly Earnings Results, Beats Expectations By $0.12 EPS

Neogen (NASDAQ:NEOG) released its quarterly earnings data on Friday. The company reported $0.11 EPS for the quarter, topping analysts’ consensus estimates of ($0.01) by $0.12, Briefing.com reports. Neogen had a positive return on equity of 2.80% and a negative net margin of 2.58%. The business had revenue of $231.30 million during the quarter, compared to the consensus estimate of $227.16 million. During the same period in the prior year, the firm posted $0.11 EPS. The business’s revenue for the quarter was up .7% on a year-over-year basis. Neogen updated its FY 2025 guidance to EPS.

Neogen Stock Up 0.7 %

NASDAQ:NEOG opened at $13.07 on Friday. The company has a current ratio of 4.41, a quick ratio of 2.79 and a debt-to-equity ratio of 0.28. The stock has a 50 day moving average of $13.54 and a 200-day moving average of $15.11. The firm has a market capitalization of $2.83 billion, a PE ratio of -118.82 and a beta of 1.23. Neogen has a 52 week low of $11.46 and a 52 week high of $18.75.

Wall Street Analyst Weigh In

Several equities analysts recently weighed in on the stock. StockNews.com upgraded shares of Neogen to a “sell” rating in a report on Monday, September 30th. Guggenheim started coverage on Neogen in a research report on Thursday, December 19th. They issued a “buy” rating and a $15.00 target price for the company.

Neogen Company Profile

Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods.